Therefore, our study suggests that LGALS3BP may be an indicator of immune infiltration in ccRCC and that LGALS3BP enhances ccRCC cell proliferation and leads to poor prognosis in patients. The gene discussed is LGALS3BP; the disease is nonpapillary renal cell carcinoma.